Search Results - "Maggioncalda, Emily C."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A mouse model of pulmonary Mycobacteroides abscessus infection by Maggioncalda, Emily C., Story-Roller, Elizabeth, Mylius, Julian, Illei, Peter, Basaraba, Randall J., Lamichhane, Gyanu

    Published in Scientific reports (28-02-2020)
    “…There is no preclinical mouse model to investigate pulmonary Mycobacteroides abscessus (formerly Mycobacterium abscessus ) infection in an immunocompetent…”
    Get full text
    Journal Article
  2. 2

    Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities by Story-Roller, Elizabeth, Maggioncalda, Emily C, Cohen, Keira A, Lamichhane, Gyanu

    Published in Frontiers in microbiology (25-09-2018)
    “…β-lactams, the most widely used class of antibiotics, are well-tolerated, and their molecular mechanisms of action against many bacteria are well-documented. (…”
    Get full text
    Journal Article
  3. 3

    Development of a penem antibiotic against Mycobacteroides abscessus by Batchelder, Hunter R., Story-Roller, Elizabeth, Lloyd, Evan P., Kaushik, Amit, Bigelow, Kristina M., Maggioncalda, Emily C., Nuermberger, Eric L., Lamichhane, Gyanu, Townsend, Craig A.

    Published in Communications biology (07-12-2020)
    “…β-lactams are the most widely used antibiotic class to treat bacterial infections in humans. Mycobacteroides abscessus is an emerging pulmonary pathogen…”
    Get full text
    Journal Article
  4. 4

    Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro by Story-Roller, Elizabeth, Maggioncalda, Emily C, Lamichhane, Gyanu

    Published in Antimicrobial agents and chemotherapy (01-04-2019)
    “…is a nontuberculous mycobacterium that causes invasive pulmonary infections in patients with structural lung disease. is intrinsically resistant to several…”
    Get full text
    Journal Article
  5. 5

    Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice by Story-Roller, Elizabeth, Maggioncalda, Emily C, Lamichhane, Gyanu

    Published in Antimicrobial agents and chemotherapy (01-08-2019)
    “…is an emerging pathogen capable of causing invasive pulmonary infections in patients with chronic lung diseases. These infections are difficult to treat,…”
    Get full text
    Journal Article
  6. 6

    Glby, Encoded by MAB_3167c , Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity by Galanis, Christos, Maggioncalda, Emily C, Kumar, Pankaj, Lamichhane, Gyanu

    Published in Journal of bacteriology (17-05-2022)
    “…Mycobacteroides abscessus ( ; also known as Mycobacterium abscessus) is an emerging opportunistic pathogen. Patients with structural lung conditions such as…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice by Sriram, Divya, Wahi, Rishi, Maggioncalda, Emily C., Panthi, Chandra M., Lamichhane, Gyanu

    Published in Tuberculosis (Edinburgh, Scotland) (01-12-2022)
    “…Mycobacteroides abscessus (Mab, also known as Mycobacterium abscessus) can cause chronic pulmonary disease in the setting of structural lung conditions…”
    Get full text
    Journal Article
  9. 9

    Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds by Batchelder, Hunter R., Zandi, Trevor A., Kaushik, Amit, Naik, Akul, Story-Roller, Elizabeth, Maggioncalda, Emily C., Lamichhane, Gyanu, Nuermberger, Eric L., Townsend, Craig A.

    Published in ACS infectious diseases (12-08-2022)
    “…The rise of antibiotic-resistant Mycobacterium tuberculosis and non-tuberculous mycobacterial infections has placed ever-increasing importance on discovering…”
    Get full text
    Journal Article
  10. 10